<DOC>
	<DOCNO>NCT00709969</DOCNO>
	<brief_summary>This study ass safety efficacy artemether-lumefantrine tablet ( 6-dose regimen ) African infant / child acute uncomplicated falciparum malaria .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Artemether-Lumefantrine Tablets African Infants Children With Uncomplicated P. Falciparum Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>male female weigh ≥ 5kg ≤ 25kg P. falciparum parasitemia 1,000 100,000 parasites/mm3 confirm diagnosis uncomplicated malaria cause P. falciparum parasite complicate malaria ingestion various antimalarial drug , drug influence cardiac function previous 4 week study entry 8 week severe anaemia severe malnutrition malaria due P. falciparum Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Malaria</keyword>
	<keyword>co-artemether</keyword>
	<keyword>auditory</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>marsh fever</keyword>
	<keyword>remittent fever</keyword>
	<keyword>artemether</keyword>
	<keyword>artemisinins</keyword>
	<keyword>lumefantrine</keyword>
	<keyword>child</keyword>
	<keyword>infant</keyword>
	<keyword>Africa</keyword>
</DOC>